Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?

Drugmakers Novo Nordisk and Eli Lilly have been making headlines in recent times, thanks to their sought-after weight loss drugs. In fact, the products have become so popular that demand has surpassed supply -- and the companies have been ramping up production to try to keep up.Novo Nordisk's Ozempic and Eli Lilly's Mounjaro are approved for type 2 diabetes, but doctors also have prescribed them for weight loss. And the companies sell the same molecules specifically approved for weight loss under different ...